Search Results

There are 5105 results for: content related to: A comparison of the effect of nanotube chirality and electronic properties on the π–π interaction of single-wall carbon nanotubes with pyrazinamide antitubercular drug

  1. You have free access to this content
    Acute liver failure due to antitubercular therapy: Strategy for antitubercular treatment before and after liver transplantation

    Liver Transplantation

    Volume 16, Issue 10, October 2010, Pages: 1136–1146, Philippe Ichai, Faouzi Saliba, Fadi Antoun, Daniel Azoulay, Mylène Sebagh, Teresa Maria Antonini, Lélia Escaut, Delvart Valérie, Denis Castaing and Didier Samuel

    Version of Record online : 30 JUN 2010, DOI: 10.1002/lt.22125

  2. Analogs of the Antituberculous Agent Pyrazinamide Are Competitive Inhibitors of NADPH Binding to M. tuberculosis Fatty Acid Synthase I

    Chemistry & Biodiversity

    Volume 9, Issue 11, November 2012, Pages: 2582–2596, Halimah Sayahi, Kaitlin M. Pugliese, Oren Zimhony, William R. Jacobs Jr., Alexander Shekhtman and John T. Welch

    Version of Record online : 19 NOV 2012, DOI: 10.1002/cbdv.201200291

  3. Pyrazinamide induced hepatic injury in rats through inhibiting the PPARα pathway

    Journal of Applied Toxicology

    Volume 36, Issue 12, December 2016, Pages: 1579–1590, Yun Zhang, Hongli Guo, Hozeifa M. Hassan, Ping-ping Ding, Yijing Su, Yuming Song, Tao Wang, Lixin Sun, Luyong Zhang and Zhenzhou Jiang

    Version of Record online : 12 APR 2016, DOI: 10.1002/jat.3319

  4. Gene expression profiling reveals potential key pathways involved in pyrazinamide-mediated hepatotoxicity in Wistar rats

    Journal of Applied Toxicology

    Volume 33, Issue 8, August 2013, Pages: 807–819, Yun Zhang, Zhenzhou Jiang, Yijing Su, Mi Chen, Fu Li, Li Liu, Lixin Sun, Yun Wang, Shuang Zhang and Luyong Zhang

    Version of Record online : 19 MAR 2012, DOI: 10.1002/jat.2736

  5. Coencapsulation of Hydrophobic and Hydrophilic Antituberculosis Drugs in Synergistic Brij 96 Microemulsions: A Biophysical Characterization

    Journal of Pharmaceutical Sciences

    Volume 104, Issue 7, July 2015, Pages: 2203–2212, Gurpreet Kaur, S.K. Mehta, Sandeep Kumar, Gaurav Bhanjana and Neeraj Dilbaghi

    Version of Record online : 7 MAY 2015, DOI: 10.1002/jps.24469

  6. Comparison of growth and susceptibility testing of pyrazinamide in different Bactec media using strains of the M. tuberculosis complex


    Volume 101, Issue 1-6, January 1993, Pages: 154–159, KURT FUURSTED

    Version of Record online : 15 AUG 2009, DOI: 10.1111/j.1699-0463.1993.tb00095.x

  7. Investigation of the effects of concomitant caffeine administration on the metabolic disposition of pyrazinamide in rats

    Biopharmaceutics & Drug Disposition

    Volume 23, Issue 5, July 2002, Pages: 191–195, Aida Mehmedagic, Philippe Verite, Sabine Menager, Christine Tharasse, Christiane Chabenat, Dominique Andre and Olivier Lafont

    Version of Record online : 24 JUN 2002, DOI: 10.1002/bdd.305

  8. You have free access to this content
    Structural basis for targeting the ribosomal protein S1 of Mycobacterium tuberculosis by pyrazinamide

    Molecular Microbiology

    Volume 95, Issue 5, March 2015, Pages: 791–803, Juanjuan Yang, Yindi Liu, Jing Bi, Qixu Cai, Xinli Liao, Wenqian Li, Chenyun Guo, Qian Zhang, Tianwei Lin, Yufen Zhao, Honghai Wang, Jun Liu, Xuelian Zhang and Donghai Lin

    Version of Record online : 16 JAN 2015, DOI: 10.1111/mmi.12892

  9. Metabolic disposition of pyrazinamide in the rat: Identification of a novel in vivo metabolite common to both rat and human

    Biopharmaceutics & Drug Disposition

    Volume 8, Issue 4, July/August 1987, Pages: 307–318, L. W. Whitehouse, B. A. Lodge, A. W. By and B. H. Thomas

    Version of Record online : 8 FEB 2006, DOI: 10.1002/bdd.2510080402

  10. Studies of the Binding of Modest Modulators of the Human Enzyme, Sirtuin 6, by STD NMR


    Volume 18, Issue 10, May 18, 2017, Pages: 931–940, Beatriz E. Bolívar and Prof. John T. Welch

    Version of Record online : 18 APR 2017, DOI: 10.1002/cbic.201600655

  11. Synthesis, solution properties and scale-inhibiting behaviour of a diallylammonium/sulfur dioxide cyclocopolymer bearing phospho- and sulfopropyl pendents

    Polymer International

    Volume 63, Issue 9, September 2014, Pages: 1682–1690, Shaikh A Ali and Shamsuddeen A Haladu

    Version of Record online : 19 FEB 2014, DOI: 10.1002/pi.4691

  12. A Ratiometric Sensor Using Single Chirality Near-Infrared Fluorescent Carbon Nanotubes: Application to In Vivo Monitoring


    Volume 11, Issue 32, August 26, 2015, Pages: 3973–3984, Juan P. Giraldo, Markita P. Landry, Seon-Yeong Kwak, Rishabh M. Jain, Min Hao Wong, Nicole M. Iverson, Micha Ben-Naim and Michael S. Strano

    Version of Record online : 15 MAY 2015, DOI: 10.1002/smll.201403276

  13. You have free access to this content
    Pyrazinamide blood concentrations in children suffering from tuberculosis: a comparative study at two doses

    British Journal of Clinical Pharmacology

    Volume 65, Issue 3, March 2008, Pages: 423–427, Pooja Gupta, Vandana Roy, Gulshan Rai Sethi and Tarun Kumar Mishra

    Version of Record online : 18 DEC 2007, DOI: 10.1111/j.1365-2125.2007.03069.x

  14. You have full text access to this OnlineOpen article
    Uricosuric targets of tranilast

    Pharmacology Research & Perspectives

    Volume 5, Issue 2, April 2017, Asim K. Mandal, Adriana Mercado, Andria Foster, Kambiz Zandi-Nejad and David B. Mount

    Version of Record online : 6 FEB 2017, DOI: 10.1002/prp2.291

  15. Population pharmacokinetics of pyrazinamide in elephants

    Journal of Veterinary Pharmacology and Therapeutics

    Volume 28, Issue 5, October 2005, Pages: 403–409, M. ZHU, J. N. MASLOW, S. K. MIKOTA, R. ISAZA, F. DUNKER, H. RIDDLE and C. A. PELOQUIN

    Version of Record online : 5 OCT 2005, DOI: 10.1111/j.1365-2885.2005.00670.x

  16. Cyclopolymerization protocol for the synthesis of a poly(zwitterion-alt-sulfur dioxide) to investigate the polyzwitterion-to-poly(anion-zwitterion) transition

    Journal of Applied Polymer Science

    Volume 129, Issue 3, 5 August 2013, Pages: 1394–1404, Shaikh A. Ali and Shamsuddeen A. Haladu

    Version of Record online : 10 DEC 2012, DOI: 10.1002/app.38835

  17. New insights into TB physiology suggest untapped therapeutic opportunities

    Immunological Reviews

    Volume 264, Issue 1, March 2015, Pages: 327–343, Christina E. Baer, Eric J. Rubin and Christopher M. Sassetti

    Version of Record online : 20 FEB 2015, DOI: 10.1111/imr.12267

  18. Pharmacokinetics of Pyrazinamide under Fasting Conditions, with Food, and with Antacids

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 18, Issue 6, November-December 1998, Pages: 1205–1211, Charles A. Peloquin, Amy E. Bulpitt, George S. Jaresko, Roger W. Jelliffe, Gordon T. James and David E. Nix

    Version of Record online : 17 JAN 2012, DOI: 10.1002/j.1875-9114.1998.tb03138.x

  19. You have free access to this content
    Beyond Randomized Trials—TB treatment in Children

    Evidence-Based Child Health: A Cochrane Review Journal

    Volume 5, Issue 4, December 2010, Pages: 1566–1577, Anna Ridge, Patti Whyte, Malgosia Grzemska, Peter Donald and Suzanne Hill

    Version of Record online : 23 DEC 2010, DOI: 10.1002/ebch.589

  20. Entrapment of multiple anti-Tb drugs in microemulsion system: Quantitative analysis, stability, and in vitro release studies

    Journal of Pharmaceutical Sciences

    Volume 99, Issue 4, April 2010, Pages: 1896–1911, S.K. Mehta, Gurpreet Kaur and K.K. Bhasin

    Version of Record online : 5 NOV 2009, DOI: 10.1002/jps.21971